Related Experiment Video
Updated: Sep 20, 2026

The Method of Rodent Whole Embryo Culture using the Rotator-type Bottle Culture System
Published on: August 28, 2010
Intellectual Property in the Field of Regenerative Medicine in Japan
Shigehiro Asano1, Yoichi Nakanishi2, Daisuke Sugiyama2
1Incubation Center for Advanced Medical Science, Kyushu University, Fukuoka, Japan.
Purpose:
Although most pharmaceutical companies and bio-ventures have not yet created a practical business model or a credible exit thus far, most are expecting potential new business to be derived from regenerative medicine. This article discusses and proposes some ideas regarding a patent strategy for regenerative medicine.
Methods:
PubMed literature searches were conducted to identify recent reports relevant to regenerative medicine. Information regarding patents and patent applications were obtained from the database service of the Japan Platform for Patent Information on the website of the National Center for Industrial Property Information and Training at https://www.j-platpat.inpit.go.jp/web/all/top/BTmTopEnglishPage and the Japan Patent Office at https://www.jpo.go.jp/index.htm.
Findings:
The infrastructure of regenerative medicine in Japan is still maturing. Patent protection is important in regenerative medicine considering its special characteristics.
Implications:
Based on the understanding of the special characteristics of regenerative medicine, this article discusses and proposes some ideas regarding a patent strategy for the field, which is different from that of a typical patent strategy as in the case of a small-molecule drug.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Somatic to iPS Cell Reprogramming
iPS Cell Differentiation
Forced Transdifferentiation
Artificial transdifferentiation occurs...
EPS and iPS Cells in Disease Research
Methods of Nuclear Reprogramming

